Biocon vs Peers
- Market cap
- ₹58,318 crore
- P/E
- 117.7
- P/B
- 1.71
- ROE
- 1.4%
- Dividend yield
- 0.14%
Biocon ranks 13th by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 117.7 compares with a peer median of 33.6.
Biocon vs Pharmaceuticals peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,773.60 | -1.69% | 4,25,546 | 35.2 | 5.09 | 14.7% | +12.5% |
| Divi's Laboratories | 9,586.00 | +0.38% | 2,54,478 | 87.0 | 15.18 | 16.2% | +12.5% |
| Torrent Pharmaceuticals | 4,693.90 | -1.64% | 1,58,863 | 72.8 | 18.94 | 27.1% | +12.5% |
| Zydus Lifesciences | 1,151.30 | -0.71% | 1,15,848 | 25.7 | 4.27 | 19.7% | +12.5% |
| Laurus Labs | 2,052.90 | +0.14% | 1,10,827 | 101.4 | 20.91 | 18.2% | +12.5% |
| Cipla | 1,333.00 | -0.54% | 1,07,677 | 32.0 | 3.13 | 11.8% | +12.5% |
| Mankind Pharma | 2,496.00 | -0.16% | 1,03,042 | 50.4 | 6.32 | 12.5% | +12.5% |
| Dr. Reddy's Laboratories | 1,194.90 | -1.08% | 99,533 | 30.1 | 2.60 | 12.1% | +12.5% |
| Aurobindo Pharma | 1,677.90 | -0.88% | 97,453 | 26.3 | 2.57 | 9.9% | +12.5% |
| Lupin | 2,006.70 | -1.11% | 91,742 | 16.6 | 4.09 | 26.9% | +12.5% |
| Biocon | 360.10 | -2.44% | 58,318 | 117.7 | 1.71 | 1.4% | +22.0% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Biocon peer comparison — frequently asked questions
Who are Biocon's competitors?
Biocon's listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.
How does Biocon's P/E compare with its peers?
Biocon trades at a P/E of 117.7, against a median of 33.6 across the 10 Pharmaceuticals peers shown.
Which is the largest company among Biocon's peers?
By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹58,318 crore for Biocon.
Same Data For Peers
Trade Biocon With ATS
Track BIOCON live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.